Salivary Gland Disorders and Diseases

  • Siri Beier JensenEmail author
  • Arjan Vissink
  • Norman Firth
Reference work entry


Saliva plays an important role in maintaining healthy oral mucosa and teeth as well as oral function by continually covering and lubricating the oral tissues. Salivary gland dysfunction designates decreased saliva flow rate (salivary gland hypofunction), increased saliva flow rate (sialorrhea or hypersalivation), and changed saliva composition. Xerostomia (the subjective feeling of oral dryness) is often associated with salivary gland hypofunction and may severely affect nutritional intake, social interaction and quality of life. Local or systemic disorders and diseases are common causes of compromised saliva secretion. Some of these are related to gland pathology or to the pathophysiological conditions of the host, whereas others affect the gland innervation or are an iatrogenic result of treatment of a disease (e.g., radiation therapy for head and neck cancer, side effects of medications). In general, many patients suffering from diseases that influence salivary gland function also undergo treatments that may impair saliva secretion and/or induce xerostomia as an adverse effect. Consequently, it can be difficult to distinguish what can be attributed to the disease per se or what can be induced by treatment (e.g., medication intake). Thus, a thorough diagnostic workup and early diagnosis of salivary gland dysfunction are crucial to provide appropriate evidence-based treatment of salivary gland dysfunction to prevent oral sequelae and to initiate individualized alleviating management strategies of xerostomia.


Salivary gland Disorders Diseases Medications Dysfunction Hyposalivation Xerostomia Hypersalivation Histopathology Sialometry Subjective/objective/semiquantitative assessment 


  1. Aberle AM, Abrams AM, Bowe R, Melrose RJ, Handlers JP. Lobular (polymorphous low-grade) carcinoma of minor salivary glands. A clinicopathologic study of twenty cases. Oral Surg Oral Med Oral Pathol. 1985;60:387–95.PubMedCrossRefPubMedCentralGoogle Scholar
  2. Agha-Hosseini F, Shirzad N, Moosavi MS. Evaluation of Xerostomia and salivary flow rate in Hashimoto's thyroiditis. Med Oral Patol Oral Cir Bucal. 2016;21:e1–5.PubMedCrossRefPubMedCentralGoogle Scholar
  3. Alajbeg I, Falcao DP, Tran SD, Martin-Granizo R, Lafaurie GI, Matranga D, Pejda S, Vuletic L, Mantilla R, Leal SC, Bezerra AC, Menard HA, Kimoto S, Pan S, Maniegas L, Krushinski CA, Melilli D, Campisi G, Paderni C, Mendoza GR, Yepes JF, Lindh L, Koray M, Mumcu G, Elad S, Zeevi I, Barrios BC, Lopez Sanchez RM, Lassauzay C, Fromentin O, Beiski BZ, Strietzel FP, Konttinen YT, Wolff A, Zunt SL. Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:773–81.PubMedCrossRefPubMedCentralGoogle Scholar
  4. Aliko A, Wolff A, Dawes C, Aframian D, Proctor G, Ekstrom J, Narayana N, Villa A, Sia YW, Joshi RK, McGowan R, Beier JS, Kerr AR, Lynge Pedersen AM, Vissink A. World workshop on oral medicine VI: clinical implications of medication-induced salivary gland dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:185–206.PubMedCrossRefPubMedCentralGoogle Scholar
  5. Altemani AMT, Martins L, Freitas F, Soares NS, Araujo and VC Araujo. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology. 2005;46:635–41.PubMedCrossRefPubMedCentralGoogle Scholar
  6. Alvarez-Canas C, Rodilla IG. True malignant mixed tumor (carcinosarcoma) of the parotid gland. Report of a case with immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996; 81:454–58.PubMedCrossRefPubMedCentralGoogle Scholar
  7. Andreoli MT, Andreoli SM, Shrime MG, Devaiah AK. Radiotherapy in parotid acinic cell carcinoma: does it have an impact on survival? Arch Otolaryngol Head Neck Surg. 2012;138:463–6.PubMedCrossRefPubMedCentralGoogle Scholar
  8. Ansai SH, Takeichi S, Arase S, Kawana and T Kimura. Sebaceous carcinoma: an immunohistochemical reappraisal. Am J Dermatopathol. 2011;33:579–87.PubMedCrossRefPubMedCentralGoogle Scholar
  9. Antonelli G, Ceccato F, Artusi C, Marinova M, Plebani M. Salivary cortisol and cortisone by LC-MS/MS: validation, reference intervals and diagnostic accuracy in Cushing's syndrome. Clin Chim Acta. 2015;451:247–51.PubMedCrossRefPubMedCentralGoogle Scholar
  10. Apple SK, Moatamed NA, Lai CK, Bhuta S. Sebaceous adenoma of the parotid gland: a case report with fine needle aspiration findings and histologic correlation. Acta Cytol. 2009;53:419–22.PubMedCrossRefPubMedCentralGoogle Scholar
  11. Arcega RS, Feinstein AJ, Bhuta S, Blackwell KE, Rao NP, Pullarkat ST. An unusual initial presentation of mantle cell lymphoma arising from the lymphoid stroma of warthin tumor. Diagn Pathol. 2015;10:209.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Barbe AG, Bock N, Derman SH, Felsch M, Timmermann L, Noack MJ. Self-assessment of oral health, dental health care and oral health-related quality of life among Parkinson's disease patients. Gerodontology. 2017;34:135–43.PubMedCrossRefPubMedCentralGoogle Scholar
  13. Bardow A, Vissink A. Saliva and caries development. In: Fejerskov O, Nyvad B, Kidd E, editors. Dental caries. The disease and its clinical management. Oxford: Wiley Blackwell; 2015. p. 83–106.Google Scholar
  14. Bardow A, Nyvad B, Nauntofte B. Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ. Arch Oral Biol. 2001;46:413–23.PubMedCrossRefPubMedCentralGoogle Scholar
  15. Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, Cowen EW, Naik H, Datiles M, Stratton P, Gress RE, Pavletic SZ. Oral disease profiles in chronic graft versus host disease. J Dent Res. 2015;94:547–54.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Bezerra TM, Monteiro BV, Henriques AC, de Vasconcelos CM, Nonaka CF, da Costa Miguel MC. Epidemiological survey of mucus extravasation phenomenon at an oral pathology referral center during a 43 year period. Braz J Otorhinolaryngol. 2016;82:536–42.PubMedCrossRefPubMedCentralGoogle Scholar
  17. Bishop JA. Unmasking MASC: bringing to light the unique morphologic, immunohistochemical and genetic features of the newly recognized mammary analogue secretory carcinoma of salivary glands. Head Neck Pathol. 2013;7:35–9.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Blasco PA, Allaire JH. Drooling in the developmentally disabled: management practices and recommendations. Consortium on drooling. Dev Med Child Neurol. 1992;34:849–62.PubMedCrossRefPubMedCentralGoogle Scholar
  19. Bootsma H, Kroese FGM, Vissink A. Rituximab in the treatment of Sjögren's syndrome: is it the wrong drug? Arthritis Rheumatol. 2017;69(7):1346–49.Google Scholar
  20. Bowman SJ, Everett CC, O'Dweyer JL, Emery P, Pitzalis C, Ng WF. Randomized controlled trial and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjögren's syndrome. Arthritis Rheumatol. 2017; 69(7):1440–50.Google Scholar
  21. Brandwein-Gensler MJ, Hille BY, Wang M, Urken R, Gordon LJ, Wang JR Simpson RH, Gnepp DR. Low-grade salivary duct carcinoma: description of 16 cases. Am J Surg Pathol. 2004;28:1040–44.PubMedCrossRefPubMedCentralGoogle Scholar
  22. Brannon RB, Sciubba JJ, Giulani M. Ductal papillomas of salivary gland origin: a report of 19 cases and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:68–77.PubMedCrossRefPubMedCentralGoogle Scholar
  23. Brierley JD, Gospodarowicz MK,Wittekind C. TNM classification of malignant tumours. Union for International Cancer Control; 2017, London.Google Scholar
  24. Brito-Zeron P, Siso-Almirall A, Bove A, Kostov BA, Ramos-Casals M. Primary Sjogren syndrome: an update on current pharmacotherapy options and future directions. Expert Opin Pharmacother. 2013;14:279–89.PubMedCrossRefPubMedCentralGoogle Scholar
  25. Brito-Zeron P, Retamozo S, Gheitasi H, Ramos-Casals M. Treating the underlying pathophysiology of primary Sjogren syndrome: recent advances and future prospects. Drugs. 2016;76:1601–23.PubMedCrossRefPubMedCentralGoogle Scholar
  26. Brito-Zeron P, Kostov B, Fraile G, Caravia-Duran D, Maure B, Rascon FJ, Zamora M, Casanovas A, Lopez-Dupla M, Ripoll M, Pinilla B, Fonseca E, Akasbi M, de la Red G, Duarte-Millan MA, Fanlo P, Guisado-Vasco P, Perez-Alvarez R, Chamorro AJ, Morcillo C, Jimenez-Heredia I, Sanchez-Berna I, Lopez-Guillermo A, Ramos-Casals M. Characterization and risk estimate of cancer in patients with primary Sjogren syndrome. J Hematol Oncol. 2017;10:90.PubMedPubMedCentralCrossRefGoogle Scholar
  27. Brook I. The bacteriology of salivary gland infections. Oral Maxillofac Surg Clin North Am. 2009;21:269–74.PubMedCrossRefPubMedCentralGoogle Scholar
  28. Buchner A, Merrell PW, Carpenter WM. Relative frequency of intra-oral minor salivary gland tumors: a study of 380 cases from northern California and comparison to reports from other parts of the world. J Oral Pathol Med. 2007;36:207–14.PubMedCrossRefPubMedCentralGoogle Scholar
  29. Bunker ML, Locker J. Warthin's tumor with malignant lymphoma. DNA analysis of paraffin-embedded tissue. Am J Clin Pathol. 1989;91:341–4.PubMedCrossRefPubMedCentralGoogle Scholar
  30. Castle JT, Thompson LD, Frommelt RA, Wenig BM, Kessler HP. Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases. Cancer. 1999;86:207–19.PubMedCrossRefPubMedCentralGoogle Scholar
  31. Catano JC, Robledo J. Tuberculous lymphadenitis and parotitis. Microbiol Spectr. 2016;4(6):
  32. Chen AM, Lau VH, Farwell DG, Luu Q, Donald PJ. Mucoepidermoid carcinoma of the parotid gland treated by surgery and postoperative radiation therapy: clinicopathologic correlates of outcome. Laryngoscope. 2013;123:3049–55.PubMedCrossRefPubMedCentralGoogle Scholar
  33. Identifier: NCT00372320 and Principal Investigator I.G.Alevizos. Effect of AdhAQP1 on salivary flow in patients treated with radiation for head and neck cancer. [The study has been completed]. 19–3-2014. Bethesda, National Institute of Dental and Craniofacial Research (NIDCR).Google Scholar
  34. Identifier: NCT02446249 and Principal Investigator J.A.Chiorini. Safety of a single administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction. [The study is currently recruiting participants, Study Start Date: 30 Apr 2015, Estimated Study Completion Date: 1 Nov 2022]. 30–4-2015. Bethesda, National Institute of Dental and Craniofacial Research (NIDCR).Google Scholar
  35. Crama-Bohbouth G, Pena AS, Verspaget HW, vd ZA, Biemond I, Weterman IT, Lamers CB. Immunological findings in whole and parotid saliva of patients with ulcerative colitis and healthy controls. Hepato-Gastroenterology. 1989;36:185–7.PubMedPubMedCentralGoogle Scholar
  36. Croitoru CM, Mooney JE, Luna MA. Sebaceous lymphadenocarcinoma of salivary glands. Ann Diagn Pathol. 2003;7:236–9.PubMedCrossRefPubMedCentralGoogle Scholar
  37. Dardick I, Thomas MJ, van Nostrand AW. Myoepithelioma – new concepts of histology and classification: a light and electron microscopic study. Ultrastruct Pathol. 1989;13:187–224.PubMedCrossRefPubMedCentralGoogle Scholar
  38. Dardick I, Ostrynski VL, Ekem JK, Leung R, Burford-Mason AP. Immunohistochemical and ultrastructural correlates of muscle-actin expression in pleomorphic adenomas and myoepitheliomas based on comparison of formalin and methanol fixation. Virchows Arch A Pathol Anat Histopathol. 1992;421:95–104.PubMedCrossRefPubMedCentralGoogle Scholar
  39. Davies H, Bagg J, Goodchild MC, McPherson MA. Examination of submandibular fluid in cystic fibrosis. Acta Univ Carol [Med ] (Praha). 1990;36:84–5.Google Scholar
  40. Davies AN, Broadley K, Beighton D. Xerostomia in patients with advanced cancer. J Pain Symptom Manag. 2001;22:820–5.CrossRefGoogle Scholar
  41. Davis PB. Pathophysiology of cystic fibrosis with emphasis on salivary gland involvement. J Dent Res. 1987;66:667–71.PubMedCrossRefPubMedCentralGoogle Scholar
  42. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res. 1987;66:648–53.PubMedCrossRefPubMedCentralGoogle Scholar
  43. Dawes C, Pedersen AM, Villa A, Ekstrom J, Proctor GB, Vissink A, Aframian D, McGowan R, Aliko A, Narayana N, Sia YW, Joshi RK, Jensen SB, Kerr AR, Wolff A. The functions of human saliva: a review sponsored by the world workshop on oral medicine VI. Arch Oral Biol. 2015;60:863–74.PubMedPubMedCentralCrossRefGoogle Scholar
  44. de Moura SA, de Sousa JM, Lima DF, Negreiros AN, Silva FV, da Costa LJ. Burning mouth syndrome (BMS): sialometric and sialochemical analysis and salivary protein profile. Gerodontology. 2007;24:173–6.PubMedCrossRefPubMedCentralGoogle Scholar
  45. De VS, Quartuccio L, Seror R, Salvin S, Ravaud P, Fabris M, Nocturne G, Gandolfo S, Isola M, Mariette X. Efficacy and safety of belimumab given for 12 months in primary Sjogren's syndrome: the BELISS open-label phase II study. Rheumatology (Oxford). 2015;54:2249–56.Google Scholar
  46. Delgado R, Klimstra D, Albores-Saavedra J. Low grade salivary duct carcinoma. A distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer. 1996;78:958–67.PubMedCrossRefPubMedCentralGoogle Scholar
  47. Delli K, Dijkstra PU, Stel AJ, Bootsma H, Vissink A, Spijkervet FK. Diagnostic properties of ultrasound of major salivary glands in Sjogren's syndrome: a meta-analysis. Oral Dis. 2015;21:792–800.PubMedCrossRefPubMedCentralGoogle Scholar
  48. Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puechal X, Le GV, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Pers JO, Nowak E, Saraux A. Treatment of primary Sjogren syndrome with rituximab: a randomized trial. Ann Intern Med. 2014;160:233–42.PubMedCrossRefPubMedCentralGoogle Scholar
  49. Dormenval V, Budtz-Jorgensen E, Mojon P, Bruyere A, Rapin CH. Associations between malnutrition, poor general health and oral dryness in hospitalized elderly patients. Age Ageing. 1998;27:123–8.PubMedCrossRefPubMedCentralGoogle Scholar
  50. Dost F, Farah CS. Stimulating the discussion on saliva substitutes: a clinical perspective. Aust Dent J. 2013;58:11–7.CrossRefGoogle Scholar
  51. Dynesen AW, Bardow A, Petersson B, Nielsen LR, Nauntofte B. Salivary changes and dental erosion in bulimia nervosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:696–707.PubMedCrossRefPubMedCentralGoogle Scholar
  52. Ekstrand T. Bell's palsy; prognostic accuracy of case history, sialometry and taste impairment. Clin Otolaryngol Allied Sci. 1979;4:183–96.PubMedCrossRefPubMedCentralGoogle Scholar
  53. Ekstrom J, Khosravani N, Castagnola M, Messana I. Saliva and the control of its secretion. In: Ekberg O, editor. Dysphagia: diagnosis and treatment. Berlin/Heidelberg: Springer; 2012. p. 19–47.Google Scholar
  54. Eliasson L, Carlen A. An update on minor salivary gland secretions. Eur J Oral Sci. 2010;118:435–42.PubMedCrossRefPubMedCentralGoogle Scholar
  55. Ellis GL, Corio RL. Acinic cell adenocarcinoma. A clinicopathologic analysis of 294 cases. Cancer. 1983;52:542–9.PubMedCrossRefPubMedCentralGoogle Scholar
  56. Ellis GL, Wiscovitch JG. Basal cell adenocarcinomas of the major salivary glands. Oral Surg Oral Med Oral Pathol.1990;69:461–9.PubMedCrossRefPubMedCentralGoogle Scholar
  57. Epstein JB, Jensen SB. Management of Hyposalivation and Xerostomia: criteria for treatment strategies. Compend Contin Educ Dent. 2015;36:600–3.PubMedPubMedCentralGoogle Scholar
  58. Ethunandan M, Pratt CA, Macpherson DW. Changing frequency of parotid gland neoplasms—analysis of 560 tumours treated in a district general hospital. Ann R Coll Surg Engl. 2002;84:1–6.PubMedPubMedCentralGoogle Scholar
  59. Fantasia JE, Nocco CE, Lally ET. Ultrastructure of sialadenoma papilliferum. Arch Pathol Lab Med. 1986;110:523–527.PubMedPubMedCentralGoogle Scholar
  60. Farah CS, Savage NW. Cryotherapy for treatment of oral lesions. Aust Dent J. 2006;51:2–5.CrossRefGoogle Scholar
  61. Fedorova T, Knudsen CS, Mouridsen K, Nexo E, Borghammer P. Salivary acetylcholinesterase activity is increased in Parkinson's disease: a potential marker of parasympathetic dysfunction. Parkinsons Dis. 2015;2015:156479.PubMedPubMedCentralGoogle Scholar
  62. Fonseca I, Soares J. Epithelial-myoepithelial carcinoma of the salivary glands. A study of 22 cases. Virchows Arch A Pathol Anat Histopathol. 1993;422:389–96.PubMedCrossRefPubMedCentralGoogle Scholar
  63. Foschini MP, Malvi D, Betts CM. Oncocytic carcinoma arising in Warthin tumour. Virchows Arch. 2005;446:88–90.PubMedCrossRefPubMedCentralGoogle Scholar
  64. Foss RD, Ellis GL, Auclair PL. Salivary gland cystadenocarcinomas. A clinicopathologic study of 57 cases. Am J Surg Pathol. 1996;20:1440–7.PubMedCrossRefPubMedCentralGoogle Scholar
  65. Fox RI. Sjogren's syndrome. Lancet. 2005;366:321–31.PubMedCrossRefPubMedCentralGoogle Scholar
  66. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc. 1987;115:581–4.PubMedCrossRefPubMedCentralGoogle Scholar
  67. Frierson HF Jr, Mills SE, Garland TA. Terminal duct carcinoma of minor salivary glands. A nonpapillary subtype of polymorphous low-grade adenocarcinoma. Am J Clin Pathol. 1985;84:8–14.PubMedCrossRefPubMedCentralGoogle Scholar
  68. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjogren's syndrome (1999): availability and validity. Mod Rheumatol. 2004;14:425–34.PubMedCrossRefPubMedCentralGoogle Scholar
  69. Furness S, Bryan G, McMillan R, Worthington HV. Interventions for the management of dry mouth: non-pharmacological interventions. Cochrane Database Syst Rev. 2013;8.
  70. Gallo A, Benazzo M, Capaccio P, De CL, De VM, Fusconi M, Martellucci S, Paludetti G, Pasquini E, Puxeddu R, Speciale R. Sialoendoscopy: state of the art, challenges and further perspectives. Round table, 101(st) SIO National Congress, Catania 2014. Acta Otorhinolaryngol Ital. 2015;35:217–33.PubMedPubMedCentralGoogle Scholar
  71. Gnepp DR. My journey into the world of salivary gland sebaceous neoplasms. Head Neck Pathol. 2012;6:101–10.PubMedPubMedCentralCrossRefGoogle Scholar
  72. Griffith CC, Thompson LD, Assaad A, Purgina BM, Lai C, Bauman JE, Weinreb I, Seethala RR, Chiosea SI. Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma. Histopathology. 2014;65:854–60.PubMedCrossRefPubMedCentralGoogle Scholar
  73. Gronhoj C, Jensen DH, Glovinski PV, Jensen SB, Bardow A, Oliveri RS, Specht L, Thomsen C, Darkner S, Kiss K, Fischer-Nielsen A, First-in-man v BC. Mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial. Trials. 2017;18:108.PubMedPubMedCentralCrossRefGoogle Scholar
  74. Grossmann SM, Teixeira R, Oliveira GC, Gleber-Netto FO, Araujo FM, Araujo FM, Carmo MA. Xerostomia, hyposalivation and sialadenitis in patients with chronic hepatitis C are not associated with the detection of HCV RNA in saliva or salivary glands. J Clin Pathol. 2010;63:1002–7.CrossRefGoogle Scholar
  75. Ha WN, Kelloway E, Dost F, Farah CSA. Retrospective analysis of oral and maxillofacial pathology in an Australian paediatric population. Aust Dent J. 2014;59:221–5.PubMedPubMedCentralCrossRefGoogle Scholar
  76. Hakansson U, Jacobsson L, Lilja B, Manthorpe R, Henriksson V. Salivary gland scintigraphy in subjects with and without symptoms of dry mouth and/or eyes, and in patients with primary Sjogren's syndrome. Scand J Rheumatol. 1994;23:326–33.PubMedCrossRefPubMedCentralGoogle Scholar
  77. Harrington N, Barry PJ, Barry SM. Dental treatment for people with cystic fibrosis. Eur Arch Paediatr Dent. 2016;17:195–203.PubMedCrossRefPubMedCentralGoogle Scholar
  78. Harrison T, Bigler L, Tucci M, Pratt L, Malamud F, Thigpen JT, Streckfus C, Younger H. Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: an exploratory study. Spec Care Dentist. 1998;18:109–12.PubMedCrossRefPubMedCentralGoogle Scholar
  79. Helenius LM, Meurman JH, Helenius I, Kari K, Hietanen J, Suuronen R, Hallikainen D, Kautiainen H, Leirisalo-Repo M, Lindqvist C. Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol Scand. 2005;63:284–93.PubMedCrossRefPubMedCentralGoogle Scholar
  80. Hunt L, Hensor EM, Nam J, Burska AN, Parmar R, Emery P, Ponchel FT. Cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals. Ann Rheum Dis. 2016;75:1884–9.PubMedCrossRefPubMedCentralGoogle Scholar
  81. Inenaga K, Ono K, Hitomi S, Kuroki A, Ujihara I. Thirst sensation and oral dryness following alcohol intake. Jpn Dent Sci Rev. 2017;53:78–85.PubMedPubMedCentralCrossRefGoogle Scholar
  82. Iro H, Zenk J. Salivary gland diseases in children. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2014;13:Doc06.PubMedPubMedCentralGoogle Scholar
  83. Izutsu KT, Sullivan KM, Schubert MM, Truelove EL, Shulman HM, Sale GE, Morton TH, Rice JC, Witherspoon RP, Storb R, Thomas ED. Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease. Transplantation. 1983;35:441–6.PubMedCrossRefPubMedCentralGoogle Scholar
  84. Janssen KM, Vissink A, de Smit MJ, Westra J, Brouwer E. Lessons to be learned from periodontitis. Curr Opin Rheumatol. 2013;25:241–7.PubMedCrossRefPubMedCentralGoogle Scholar
  85. Jensen SB, Mouridsen HT, Reibel J, Brünner N, Nauntofte B. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction. Oral Oncol. 2008;44:162–73.PubMedCrossRefPubMedCentralGoogle Scholar
  86. Jensen SB, Pedersen AML, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NNF, Mello ALS, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FKL, Brennan MTA. Systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18:1039–60.PubMedCrossRefPubMedCentralGoogle Scholar
  87. Jongerius PH, Joosten F, Hoogen FJ, Gabreels FJ, Rotteveel JJ. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type a into the salivary glands. Laryngoscope. 2003;113:107–11.PubMedCrossRefPubMedCentralGoogle Scholar
  88. Jousse-Joulin S, Milic V, Jonsson MV, Plagou A, Theander E, Luciano N, Rachele P, Baldini C, Bootsma H, Vissink A, Hocevar A, De VS, Tzioufas AG, Alavi Z, Bowman SJ, Devauchelle-Pensec VI. Salivary gland ultrasonography a useful tool in Sjogren's syndrome? A systematic review. Rheumatology (Oxford). 2016;55:789–800.CrossRefGoogle Scholar
  89. Juusela P, Tanskanen M, Nieminen A, Kari K, Suominen L, Uitto VJ, Kiuru-Enari S. Xerostomia in hereditary gelsolin amyloidosis. Amyloid. 2013;20:39–44.PubMedCrossRefPubMedCentralGoogle Scholar
  90. Kalk WW, Vissink A, Spijkervet FK, Bootsma H, Kallenberg CG, Nieuw Amerongen AV. Sialometry and sialochemistry: diagnostic tools for Sjogren's syndrome. Ann Rheum Dis. 2001;60:1110–6.PubMedPubMedCentralCrossRefGoogle Scholar
  91. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385:1460–71.PubMedCrossRefPubMedCentralGoogle Scholar
  92. Katz J, Shenkman A, Stavropoulos F, Melzer E. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis. 2003;9:34–40.PubMedCrossRefPubMedCentralGoogle Scholar
  93. Kelloway E, Ha WN, Dost F, Farah CSA. Retrospective analysis of oral and maxillofacial pathology in an Australian adult population. Aust Dent J. 2014;59:215–20.PubMedPubMedCentralCrossRefGoogle Scholar
  94. Kerr GD, Sellars C, Bowie L, Bagg J, Sweeney MP, Langhorne P, Stott DJ. Xerostomia after acute stroke. Cerebrovasc Dis. 2009;28:624–6.PubMedCrossRefPubMedCentralGoogle Scholar
  95. Kimple AJ, Austin GK, Shah RN, Welch CM, Funkhouser WK, Zanation AM, Shockley WW. Polymorphous low-grade adenocarcinoma: a case series and determination of recurrence. Laryngoscope. 2014;124:2714–9.PubMedPubMedCentralCrossRefGoogle Scholar
  96. Klein Hesselink EN, Links TP. Radioiodine treatment and thyroid hormone suppression therapy for differentiated thyroid carcinoma: adverse effects support the trend toward less aggressive treatment for low-risk patients. Eur Thyroid J. 2015;4:82–92.PubMedPubMedCentralCrossRefGoogle Scholar
  97. Klein Hesselink EN, Brouwers AH, de Jong JR, van der Horst-Schrivers AN, Coppes RP, Lefrandt JD, Jager PL, Vissink A, Links TP. Effects of radioiodine treatment on salivary gland function in patients with differentiated thyroid carcinoma: a prospective study. J Nucl Med. 2016;57:1685–91.PubMedCrossRefPubMedCentralGoogle Scholar
  98. Kubota Y, Kubo C Mori Y. Sialadenoma papilliferum of the hard palate: a case report. J Oral Maxillofac Surg. 2012;70:1609–12.PubMedCrossRefPubMedCentralGoogle Scholar
  99. Kuo YJ, Weinreb I, Perez-Ordonez B. Low-grade salivary duct carcinoma or low-grade intraductal carcinoma? Review of the literature. Head Neck Pathol. 2013;7 Suppl 1: S59-67.PubMedCrossRefPubMedCentralGoogle Scholar
  100. Lagerlof F, Oliveby A. Caries-protective factors in saliva. Adv Dent Res. 1994;8:229–38.PubMedCrossRefPubMedCentralGoogle Scholar
  101. Lai G, Nemolato S, Lecca S, Parodo G, Medda C, Faa G. The role of immunohistochemistry in the diagnosis of hyalinizing clear cell carcinoma of the minor salivary gland: a case report. Eur J Histochem. 2008;52:251–4.PubMedCrossRefPubMedCentralGoogle Scholar
  102. Lajer C, Buchwald C, Nauntofte B, Specht L, Bardow A, Jensdottir T. Erosive potential of saliva stimulating tablets with and without fluoride in irradiated head and neck cancer patients. Radiother Oncol. 2009;93:534–8.PubMedCrossRefPubMedCentralGoogle Scholar
  103. Lee AC, Lim WL, So KT. Epstein-Barr virus associated parotitis. J Paediatr Child Health. 1997;33:177–8.PubMedCrossRefPubMedCentralGoogle Scholar
  104. Leerdam CM, Martin HC, Isaacs D. Recurrent parotitis of childhood. J Paediatr Child Health. 2005;41:631–4.PubMedCrossRefPubMedCentralGoogle Scholar
  105. Lenander-Lumikari M, Loimaranta V. Saliva and dental caries. Adv Dent Res. 2000;14:40–7.PubMedCrossRefPubMedCentralGoogle Scholar
  106. Lexner MO, Bardow A, Hertz JM, Almer L, Nauntofte B, Kreiborg S. Whole saliva in X-linked hypohidrotic ectodermal dysplasia. Int J Paediatr Dent. 2007;17:155–62.PubMedCrossRefPubMedCentralGoogle Scholar
  107. Li LJ. Clinical analysis of salivary gland tumor cases in West China in past 50 years. Oral Oncol. 2014;44:187–92.CrossRefGoogle Scholar
  108. Lin AL, Johnson DA, Stephan KT, Yeh CK. Alteration in salivary function in early HIV infection. J Dent Res. 2003;82:719–24.PubMedCrossRefPubMedCentralGoogle Scholar
  109. Liu G, He J, Zhang C, Fu S, He Y. Lymphadenoma of the salivary gland: report of 10 cases. Oncol Lett. 2014;7:1097–101.PubMedPubMedCentralCrossRefGoogle Scholar
  110. Lopez-Pintor RM, Casanas E, Gonzalez-Serrano J, Serrano J, Ramirez L, de Arriba L, Hernandez G. Xerostomia, Hyposalivation, and salivary flow in diabetes patients. J Diabetes Res. 2016;2016:4372852.PubMedPubMedCentralCrossRefGoogle Scholar
  111. Loyola Rodriguez JP, Galvan Torres LJ, Martinez Martinez RE, Abud MC, Medina Solis CE, Ramos CS, Garcia Cortes JO, Dominguez Perez RA. Frequency of dental caries in active and inactive systemic lupus erythematous patients: salivary and bacterial factors. Lupus. 2016;25:1349–56.PubMedCrossRefPubMedCentralGoogle Scholar
  112. Machado RA, Moubayed SP, Khorsandi A, Hernandez-Prera JC, Urken ML. Intermittent facial spasms as the presenting sign of a recurrent pleomorphic adenoma. World J Clin Oncol. 2017;8:86–90.PubMedPubMedCentralCrossRefGoogle Scholar
  113. Mahajan D, Khurana N, Setia N. Sialadenoma papilliferum in a young patient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:e51-54.PubMedCrossRefPubMedCentralGoogle Scholar
  114. Maiorano E, et al. Sialadenoma papilliferum: an immunohistochemical study of five cases. J Oral Pathol Med. 1996;25(6):336–42.PubMedCrossRefPubMedCentralGoogle Scholar
  115. Majewska H, Skálová A, Stodulski D, Klimková A, Steiner P, Stankiewicz C, Biernat W. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement. Virchows Arch. 2015;466(3):245–54. Scholar
  116. Malicka B, Kaczmarek U, Skoskiewicz-Malinowska K. Prevalence of xerostomia and the salivary flow rate in diabetic patients. Adv Clin Exp Med. 2014;23:225–33.PubMedCrossRefPubMedCentralGoogle Scholar
  117. Mang FW, Michieletti P, O'Rourke K, Cauch-Dudek K, Diamant N, Bookman A, Heathcote J. Primary biliary cirrhosis, sicca complex, and dysphagia. Dysphagia. 1997;12:167–70.PubMedCrossRefPubMedCentralGoogle Scholar
  118. Manteghi A, Zwillenberg S, Arguello-Guerra V. Sebaceous carcinoma of the parotid gland: a case report and review of the literature. Ear Nose Throat J. 2014;93:E29–32.PubMedCrossRefPubMedCentralGoogle Scholar
  119. McHugh JB, Hoschar AP, Dvorakova M, Parwani AV, Barnes EL, Seethala RR. p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma. Head Neck Pathol. 2007;1:123–31.PubMedPubMedCentralCrossRefGoogle Scholar
  120. McNamara ZJ, Batstone M, Farah CS. Carcinoma ex pleomorphic adenoma in a minor salivary gland of the upper lip. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:e51–3.PubMedCrossRefPubMedCentralGoogle Scholar
  121. Meijer JM, Schonland SO, Palladini G, Merlini G, Hegenbart U, Ciocca O, Perfetti V, Leijsma MK, Bootsma H, Hazenberg BP. Sjogren's syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity? Arthritis Rheum. 2008;58:1992–9.PubMedCrossRefPubMedCentralGoogle Scholar
  122. Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H. Effectiveness of rituximab treatment in primary Sjogren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010;62:960–8.PubMedCrossRefPubMedCentralGoogle Scholar
  123. Meiners PM, Meijer JM, Vissink A, Bootsma H. Management of Sjögren's syndrome. In: Weisman MH, Weinblatt ME, Louie JS, van Vollenhoven R, editors. Targeted treatment of the rheumatic diseases. Philadelphia: Saunders; 2010. p. 133–55.CrossRefGoogle Scholar
  124. Meiners PM, Vissink A, Kroese FG, Spijkervet FK, Smitt-Kamminga NS, Abdulahad WH, Bulthuis-Kuiper J, Brouwer E, Arends S, Bootsma H. Abatacept treatment reduces disease activity in early primary Sjogren's syndrome (open-label proof of concept ASAP study). Ann Rheum Dis. 2014;73:1393–6.PubMedCrossRefPubMedCentralGoogle Scholar
  125. Meurman JH, Laine P, Keinanen S, Pyrhonen S, Teerenhovi L, Lindqvist C. Five-year follow-up of saliva in patients treated for lymphomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:447–52.PubMedCrossRefPubMedCentralGoogle Scholar
  126. Milchgrub S, Gnepp DR, Vuitch F, Delgado R, Albores-Saavedra J. Hyalinizing clear cell carcinoma of salivary gland. Am J Surg Pathol. 1994;18:74–82.PubMedCrossRefPubMedCentralGoogle Scholar
  127. Moerman RV, Bootsma H, Kroese FG, Vissink A. Sjogren's syndrome in older patients: aetiology, diagnosis and management. Drugs Aging. 2013;30:137–53.PubMedCrossRefPubMedCentralGoogle Scholar
  128. Montecchi PP, Custureri V, Polimeni A, Cordaro M, Costa L, Marinucci S, Montecchi F. Oral manifestations in a group of young patients with anorexia nervosa. Eat Weight Disord. 2003;8:164–7.PubMedCrossRefPubMedCentralGoogle Scholar
  129. Mossel E, Delli K, van Nimwegen JF, Stel AJ, Kroese FGM, Spijkervet FKL, Vissink A, Arends S, Bootsma H. Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjogren's syndrome. Ann Rheum Dis 2017; Scholar
  130. Muralidharan D, Fareed N, Pradeep PV, Margabandhu S, Ramalingam K, Ajith Kumar BV. Qualitative and quantitative changes in saliva among patients with thyroid dysfunction prior to and following the treatment of the dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115:617–23.PubMedCrossRefPubMedCentralGoogle Scholar
  131. Murray TW, Poulton R, Mark BJ, Al-Kubaisy S. Xerostomia and medications among 32-year-olds. Acta Odontol Scand. 2006;64:249–54.CrossRefGoogle Scholar
  132. Nagao T, Sugano I, Ishida Y, Tajima Y, Furuya N, Kondo Y, Nagao K. Mucoepidermoid carcinoma arising in Warthin's tumour of the parotid gland: report of two cases with histopathological, ultrastructural and immunohistochemical studies. Histopathology. 1998;33:379–86.PubMedCrossRefPubMedCentralGoogle Scholar
  133. Nagler RM, Nagler A. Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease—a prolonged study. Cancer Investig. 2003;21:34–40.CrossRefGoogle Scholar
  134. Napenas JJ, Miles L, Guajardo-Streckfus C, Streckfus CF. Salivary flow rates among women diagnosed with benign and malignant tumors. Spec Care Dentist. 2013;33:102–10.PubMedCrossRefPubMedCentralGoogle Scholar
  135. Narhi TO, Meurman JH, Ainamo A, Nevalainen JM, Schmidt-Kaunisaho KG, Siukosaari P, Valvanne J, Erkinjuntti T, Tilvis R, Makila E. Association between salivary flow rate and the use of systemic medication among 76-, 81-, and 86-year-old inhabitants in Helsinki, Finland. J Dent Res. 1992;71:1875–80.PubMedCrossRefPubMedCentralGoogle Scholar
  136. Navazesh M, Christensen CMA. Comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res. 1982;61:1158–62.PubMedCrossRefPubMedCentralGoogle Scholar
  137. Navazesh M, Wood GJ, Brightman VJ. Relationship between salivary flow rates and Candida Albicans counts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:284–8.PubMedCrossRefPubMedCentralGoogle Scholar
  138. Navazesh M, Mulligan R, Barron Y, Redford M, Greenspan D, Alves M, Phelan J. A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's interagency HIV study participants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:693–8.PubMedCrossRefPubMedCentralGoogle Scholar
  139. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50:380–6.PubMedCrossRefPubMedCentralGoogle Scholar
  140. Nieto-Gonzalez JC, Monteagudo I, Bello N, Martinez-Estupinan L, Naredo E, Carreno L. Salivary gland ultrasound in children: a useful tool in the diagnosis of juvenile Sjogren's syndrome. Clin Exp Rheumatol. 2014;32:578–80.PubMedPubMedCentralGoogle Scholar
  141. Nikitakis NG, Tosios KI, Papanikolaou VS, Rivera H, Papanicolaou SI, Ioffe OB. Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors. Mod Pathol. 2004;17:407–15.PubMedCrossRefPubMedCentralGoogle Scholar
  142. Noaiseh G, Baker JF, Vivino FB. Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sjogren's syndrome. Clin Exp Rheumatol. 2014;32:575–7.PubMedPubMedCentralGoogle Scholar
  143. Noseri H, Erden T, Toros S, Habesoglu M, Egeli E, Aker F, Cetin S. Intraductal papilloma of the parotid gland in a child. Eur Arch Otorhinolaryngol. 2007;264:1385–6.PubMedCrossRefPubMedCentralGoogle Scholar
  144. Patel DK, Morton RP. Demographics of benign parotid tumours: Warthin's tumour versus other benign salivary tumours. Acta Otolaryngol. 2016;136:83–6.PubMedCrossRefPubMedCentralGoogle Scholar
  145. Patel TD, Vazquez A, Marchiano E, Park RC, Baredes S, Eloy JA. Polymorphous low-grade adenocarcinoma of the head and neck: a population-based study of 460 cases. Laryngoscope. 2015;125:1644–9.PubMedCrossRefPubMedCentralGoogle Scholar
  146. Pedersen AM, Bardow A, Jensen SB, Nauntofte B. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis. 2002;8:117–29.PubMedCrossRefPubMedCentralGoogle Scholar
  147. Pedersen AML, Dynesen AW, Jensen SB. Udredning af xerostomi og hyposalivation. Tandlægebladet [in Danish] 2011;115:374–382.Google Scholar
  148. Peric T, Markovic D, Petrovic B, Radojevic V, Todorovic T, Radicevic BA, Heinemann RJ, Susic G, Popadic AP, Spiric VT. Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome. Clin Oral Investig. 2015;19:2153–65.PubMedCrossRefPubMedCentralGoogle Scholar
  149. Perumal CJ, Meyer M, Mohamed AA. Giant pleomorphic adenoma of the submandibular salivary gland: a case report. Craniomaxillofac Trauma Reconstr. 2012;5:185–8.PubMedPubMedCentralCrossRefGoogle Scholar
  150. Pijpe J, Kalk WW, van der Wal JE, Vissink A, Kluin PM, Roodenburg JL, Bootsma H, Kallenberg CG, Spijkervet FK. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome. Rheumatology (Oxford). 2007;46:335–41.CrossRefGoogle Scholar
  151. Pimentel MT, López Amado M, García Sarandeses A. Recurrent sialadenoma papilliferum of the buccal mucosa. J Laryngol Otol. 1995;109:787–90.PubMedCrossRefPubMedCentralGoogle Scholar
  152. Pires FR, Pringle GA, de Almeida OP, Chen SY. Intra-oral minor salivary gland tumors: a clinicopathological study of 546 cases. Oral Oncol. 43(5):463–70.PubMedCrossRefPubMedCentralGoogle Scholar
  153. Pollard RP, Pijpe J, Bootsma H, Spijkervet FK, Kluin PM, Roodenburg JL, Kallenberg CG, Vissink A, van Imhoff GW. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study. J Rheumatol. 2011;38:2198–208.PubMedCrossRefPubMedCentralGoogle Scholar
  154. Pringle S, Maimets M, van der Zwaag M, Stokman MA, van Gosliga D, Zwart E, Witjes MJ, de Haan G, van Os R, Coppes RP. Human salivary gland stem cells functionally restore radiation damaged salivary glands. Stem Cells. 2016;34:640–52.PubMedCrossRefPubMedCentralGoogle Scholar
  155. Proctor GB, Carpenter GH. Regulation of salivary gland function by autonomic nerves. Auton Neurosci. 2007;133:3–18.PubMedCrossRefPubMedCentralGoogle Scholar
  156. Prokaeva T, Spencer B, Kaut M, Ozonoff A, Doros G, Connors LH, Skinner M, Seldin DC. Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival. Arthritis Rheum. 2007;56:3858–68.PubMedCrossRefPubMedCentralGoogle Scholar
  157. Puhakka A, Forssell H, Soinila S, Virtanen A, Roytta M, Laine M, Tenovuo O, Teerijoki-Oksa T, Jaaskelainen SK. Peripheral nervous system involvement in primary burning mouth syndrome—results of a pilot study. Oral Dis. 2016;22:338–44.PubMedCrossRefPubMedCentralGoogle Scholar
  158. Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R. Epidemiology of primary Sjogren's syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:1983–9.PubMedCrossRefPubMedCentralGoogle Scholar
  159. Quer M, Vander PV, Takes RP, Silver CE, Boedeker CC, de Bree R, Rinaldo A, Sanabria A, Shaha AR, Pujol A, Zbaren P, Ferlito A. Surgical options in benign parotid tumors: a proposal for classification. Eur Arch Otorhinolaryngol 2017;274:3825.PubMedCrossRefPubMedCentralGoogle Scholar
  160. Ramos-Casals M, Brito-Zeron P, Garcia-Carrasco M, Font J. Sarcoidosis or Sjogren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore). 2004;83:85–95.CrossRefGoogle Scholar
  161. Rantapaa-Dahlqvist S. What happens before the onset of rheumatoid arthritis? Curr Opin Rheumatol. 2009;21:272–8.PubMedCrossRefPubMedCentralGoogle Scholar
  162. Regelink G, Vissink A, Reintsema H, Nauta JM. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int. 1998;29:383–8.PubMedPubMedCentralGoogle Scholar
  163. Restituto P, Galofre JC, Gil MJ, Mugueta C, Santos S, Monreal JI, Varo N. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders. Clin Biochem. 2008;41:688–92.PubMedCrossRefPubMedCentralGoogle Scholar
  164. Rhodus NL, Fricton J, Carlson P, Messner R. Oral symptoms associated with fibromyalgia syndrome. J Rheumatol. 2003;30:1841–5.PubMedGoogle Scholar
  165. Ruiz E, Alegre J, Garcia Quintana AM, Aliste L, Blazquez A, de Sevilla TF. Chronic fatigue syndrome: study of a consecutive series of 824 cases assessed in two specialized units. Rev Clin Esp. 2011;211:385–90.Google Scholar
  166. Saeves R, Nordgarden H, Storhaug K, Sandvik L, Espelid I. Salivary flow rate and oral findings in Prader-Willi syndrome: a case-control study. Int J Paediatr Dent. 2012;22:27–36.PubMedCrossRefPubMedCentralGoogle Scholar
  167. Salaffi F, Argalia G, Carotti M, Giannini FB, Palombi C. Salivary gland ultrasonography in the evaluation of primary Sjogren's syndrome. Comparison with minor salivary gland biopsy. J Rheumatol. 2000;27:1229–36.PubMedPubMedCentralGoogle Scholar
  168. Santos MT, Guare R, Leite M, Ferreira MC, Nicolau J. Does the neuromotor abnormality type affect the salivary parameters in individuals with cerebral palsy? J Oral Pathol Med. 2010;39:770–4.PubMedCrossRefPubMedCentralGoogle Scholar
  169. Sciubba JJ, Brannon RB. Myoepithelioma of salivary glands: Report of 23 cases. Cancer. 1982;49:562–72.PubMedCrossRefPubMedCentralGoogle Scholar
  170. Seethala RR, Thompson LD, Gnepp DR, Barnes EL, Skalova A, Montone K, Kane S, Lewis JS Jr, Solomon LW, Simpson RH, Khan A, Prasad ML. Lymphadenoma of the salivary gland: clinicopathological and immunohistochemical analysis of 33 tumors. Mod Pathol. 2012;25:26–35.PubMedCrossRefPubMedCentralGoogle Scholar
  171. Sheetal A, Hiremath VK, Patil AG, Sajjansetty S, Kumar SR. Malnutrition and its oral outcome - a review. J Clin Diagn Res. 2013;7:178–80.PubMedPubMedCentralGoogle Scholar
  172. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X. 2016 American College of Rheumatology/European league against rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76:9–16.PubMedCrossRefPubMedCentralGoogle Scholar
  173. Ship JA, Fischer DJ. The relationship between dehydration and parotid salivary gland function in young and older healthy adults. J Gerontol A Biol Sci Med Sci. 1997;52:M310–9.PubMedCrossRefPubMedCentralGoogle Scholar
  174. Ship JA, DeCarli C, Friedland RP, Baum BJ. Diminished submandibular salivary flow in dementia of the Alzheimer type. J Gerontol. 1990;45:M61–6.PubMedCrossRefPubMedCentralGoogle Scholar
  175. Silvestre-Rangil J, Bagan L, Silvestre FJ, Bagan JV. Oral manifestations of rheumatoid arthritis. A cross-sectional study of 73 patients. Clin Oral Investig. 2016;20:2575–80.PubMedCrossRefPubMedCentralGoogle Scholar
  176. Sirois DA, Natelson B. Clinicopathological findings consistent with primary Sjogren's syndrome in a subset of patients diagnosed with chronic fatigue syndrome: preliminary observations. J Rheumatol. 2001;28:126–31.PubMedPubMedCentralGoogle Scholar
  177. Skalova A. Mammary analogue secretory carcinoma of salivary gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity. Head Neck Pathol. 2013;7 Suppl 1:S30-36.PubMedCrossRefPubMedCentralGoogle Scholar
  178. Skalova A, Michal M, Nathansky Z. Epidermoid carcinoma arising in Warthin's tumour: a case study. J Oral Pathol Med. 1994;23:330–3.PubMedCrossRefPubMedCentralGoogle Scholar
  179. Skalova A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, Starek I, Geierova M, Simpson RH, Passador-Santos F, Ryska A, Leivo I, Kinkor Z, Michal M. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599–608.PubMedPubMedCentralGoogle Scholar
  180. Smidt D, Torpet L A, Nauntofte B, Heegaard K M, Pedersen A M. Associations between oral and ocular dryness, labial and whole salivary flow rates, systemic diseases and medications in a sample of older people. Community Dent Oral Epidemiol 2010;39(3):276–88.PubMedCrossRefPubMedCentralGoogle Scholar
  181. Spiro RH, Huvos AG, Strong EW. Adenocarcinoma of salivary origin. Clinicopathologic study of 204 patients. Am J Surg. 1982;144:423–31.PubMedCrossRefPubMedCentralGoogle Scholar
  182. Sreebny LM. The enigma of dry mouth. Dry mouth: a common worldwide tormentor. In: Sreebny LM, Vissink A, editors. Dry mouth – the malevolent symptom: a clinical guide. Iowa: Wiley-Blackwell; 2010. p. 3–9.Google Scholar
  183. Sreebny LM, Vissink A, editors. Dry mouth – the malevolent symptom: a clinical guide. Iowa: Wiley-Blackwell; 2010.Google Scholar
  184. Stegenga B, Vissink A, de Bont LGM, Spijkervet FKL (Eds). MKA chirurgie. Handboek voor Mondziekten, Kaak‐ en Aangezichtschirurgie. Assen: van Gorcum. Chapter 7: Spijkervet FKL, Vissink A. Afwijkingen van speeksel en speekselklieren; 2013, p 244.Google Scholar
  185. Szanto A, Nagy G, Molnar CS, Griger Z, Tarr T, Zeher M. Description of patients with IgG4-related disease from a Hungarian centre. Scand J Rheumatol. 2014;43:334–7.PubMedCrossRefPubMedCentralGoogle Scholar
  186. Takashima S, Morimoto S, Tomiyama N, Takeuchi N, Ikezoe J, Kozuka T. Sjogren syndrome: comparison of sialography and ultrasonography. J Clin Ultrasound. 1992;20:99–109.PubMedCrossRefPubMedCentralGoogle Scholar
  187. Takada Y, Kawamoto K, Baba S, Takada T, Inoue T, Tomoda K. Sebaceous carcinoma of the parotid gland: a case report. Case Rep Oncol. 2015;8:106–12.PubMedPubMedCentralCrossRefGoogle Scholar
  188. Tarsitano A, Pizzigallo A, Giorgini F, Marchetti C. Giant pleomorphic adenoma of the parotid gland: an unusual case presentation and literature review. Acta Otorhinolaryngol Ital. 2015;35:293–6.PubMedPubMedCentralGoogle Scholar
  189. Thompson LD, Bauer JL, Chiosea S, McHugh JB, Seethala RR, Miettinen M, Müller S. Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature. Head Neck Pathol. 2015;9:181–95.PubMedCrossRefPubMedCentralGoogle Scholar
  190. Thompson LD, Wenig BM, Ellis GL. Oncocytomas of the submandibular gland. A series of 22 cases and a review of the literature. Cancer. 1996;78:2281–7.PubMedCrossRefPubMedCentralGoogle Scholar
  191. Tjioe KC, de Lima HG, Thompson LD, Lara VS, Damante JH, de Oliveira-Santos C. Papillary cystadenoma of minor salivary glands: report of 11 cases and review of the english literature. Head Neck Pathol. 2015;9:354–9.PubMedCrossRefPubMedCentralGoogle Scholar
  192. Tribius S, Raguse M, Voigt C, Munscher A, Grobe A, Petersen C, Krull A, Bergelt C, Singer S. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: results of a prospective study. Strahlenther Onkol. 2015;191:501–10.PubMedCrossRefPubMedCentralGoogle Scholar
  193. Trouw LA, Haisma EM, Levarht EW, van der Woude D, Ioan-Facsinay A, Daha MR, Huizinga TW, Toes RE. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum. 2009;60:1923–31.PubMedCrossRefPubMedCentralGoogle Scholar
  194. Tuttolomondo A, Simonetta I, Di R D, Conigliaro R, Corpora F, Vassallo V, Pinto A. A Case report of IgG4-related syndrome and literature review. Curr Pharm Des 2016 [Epub ahead of print].Google Scholar
  195. Ubaidat MA, Robinson RA, Belding PJ, Merryman DJ. Sialadenoma papilliferum of the hard palate: report of 2 cases and immunohistochemical evaluation. Arch Pathol Lab Med. 2001;125:1595–7.PubMedPubMedCentralGoogle Scholar
  196. Uemaetomari I, Tabuchi K, Tobita T, Tsuji S, Wada T, Kamma H, Hara A. The importance of postoperative radiotherapy against polymorphous low-grade adenocarcinoma of the parotid gland: case report and review of the literature. Tohoku J Exp Med. 2007;211:297–302.PubMedCrossRefPubMedCentralGoogle Scholar
  197. van de Stadt LA, van der Horst AR, de Koning MH, Bos WH, Wolbink GJ, van de Stadt RJ, Pruijn GJ, Dijkmans BA, van Schaardenburg D, Hamann D. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis. 2011;70:128–33.PubMedCrossRefPubMedCentralGoogle Scholar
  198. van den Berg I, Pijpe J, Vissink A. Salivary gland parameters and clinical data related to the underlying disorder in patients with persisting xerostomia. Eur J Oral Sci. 2007;115:97–102.PubMedCrossRefPubMedCentralGoogle Scholar
  199. van Luijk P, Pringle S, Deasy JO, Moiseenko VV, Faber H, Hovan A, Baanstra M, van der Laan HP, Kierkels RG, van der Schaaf A, Witjes MJ, Schippers JM, Brandenburg S, Langendijk JA, Wu J, Coppes RP. Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer. Sci Transl Med. 2015;7:305ra147.PubMedPubMedCentralCrossRefGoogle Scholar
  200. van Nimwegen JF, Moerman RV, Sillevis SN, Brouwer E, Bootsma H, Vissink A. Safety of treatments for primary Sjogren's syndrome. Expert Opin Drug Saf. 2016;15:513–24.PubMedCrossRefPubMedCentralGoogle Scholar
  201. Verstappen GM, Kroese FG, Vissink A, Bootsma H. Pharmacotherapy for managing extraglandular symptoms of primary Sjögren's syndrome. Expert Opin Orphan Drugs. 2015;3:125–39.CrossRefGoogle Scholar
  202. Villa A, Wolff A, Aframian D, Vissink A, Ekstrom J, Proctor G, McGowan R, Narayana N, Aliko A, Sia YW, Joshi RK, Jensen SB, Kerr AR, Dawes C, Pedersen AM. World workshop on oral medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment. Clin Oral Investig. 2015;19:1563–80.CrossRefGoogle Scholar
  203. Villa A, Wolff A, Narayana N, Dawes C, Aframian DJ, Lynge Pedersen AM, Vissink A, Aliko A, Sia YW, Joshi RK, McGowan R, Jensen SB, Kerr AR, Ekstrom J, Proctor G. World workshop on oral medicine VI: a systematic review of medication-induced salivary gland dysfunction. Oral Dis. 2016;22:365–82.PubMedCrossRefPubMedCentralGoogle Scholar
  204. Vissink A. Other ways to assess salivary gland disease. In: Sreebny LM, Vissink A, editors. Dry mouth – the malevolent symptom: a clinical guide. Iowa: Wiley-Blackwell; 2010. p. 77–88.Google Scholar
  205. Vissink A, Gravenmade EJ, Panders AK, Vermey A, Petersen JK, Visch LL, Schaub RMA. Clinical comparison between commercially available mucin- and CMC-containing saliva substitutes. Int J Oral Surg. 1983;12:232–8.PubMedCrossRefPubMedCentralGoogle Scholar
  206. Vissink A, De Jong HP, Busscher HJ, Arends J, Gravenmade EJ. Wetting properties of human saliva and saliva substitutes. J Dent Res. 1986;65:1121–4.PubMedCrossRefPubMedCentralGoogle Scholar
  207. Vissink A, van Luijk P, Langendijk JA, Coppes RP. Current ideas to reduce or salvage radiation damage to salivary glands. Oral Dis. 2015;21:e1–10.PubMedCrossRefPubMedCentralGoogle Scholar
  208. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61:554–8.PubMedPubMedCentralCrossRefGoogle Scholar
  209. Voulgarelis M, Skopouli FN. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients. Clin Rev Allergy Immunol. 2007;32:265–74.PubMedCrossRefPubMedCentralGoogle Scholar
  210. Walls AW, Steele JG. The relationship between oral health and nutrition in older people. Mech Ageing Dev. 2004;125:853–7.PubMedCrossRefPubMedCentralGoogle Scholar
  211. Waldron CA, el-Mofty SK, Gnepp DR. Tumors of the intraoral minor salivary glands: a demographic and histologic study of 426 cases. Oral Surg Oral Med Oral Pathol. 1988;66:323–33.PubMedCrossRefPubMedCentralGoogle Scholar
  212. Wang D, Li Y, He H, Liu L, Wu L, He Z. Intraoral minor salivary gland tumors in a Chinese population: a retrospective study on 737 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:94–100.PubMedCrossRefPubMedCentralGoogle Scholar
  213. Wang XD, Meng LJ, Hou TT, Zheng C, Huang SH. Frequency and distribution pattern of minor salivary gland tumors in a northeastern Chinese population: a retrospective study of 485 patients. J Oral Maxillofac Surg. 2015;73:81–91.PubMedCrossRefPubMedCentralGoogle Scholar
  214. Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, Hamann S, Larkin G, McNamara NA, Greenspan JS, Daniels TEA. Simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren’s syndrome international registry. Am J Ophthalmol. 2010;149:405–15.PubMedCrossRefPubMedCentralGoogle Scholar
  215. WHO. Classification of Head and Neck Tumours. In: El-Naggar AK, Chan J, Grandis J, Takata T, Slootweg PJ, editors. Lyon: IARC Press; 2017.Google Scholar
  216. Willemze A, Trouw LA, Toes RE, Huizinga TW. The influence of ACPA status and characteristics on the course of RA. Nat Rev Rheumatol. 2012;8:144–52.PubMedCrossRefPubMedCentralGoogle Scholar
  217. Williamson JD, Simmons BH, el-Naggar A, Medeiros LJ. Mucoepidermoid carcinoma involving Warthin tumor. A report of five cases and review of the literature. Am J Clin Pathol. 2000;114:564–70.PubMedCrossRefPubMedCentralGoogle Scholar
  218. Wilson TC, Robinson RA. Basal cell adenocarcinoma and Basal cell adenoma of the salivary glands: a clinicopathological review of seventy tumors with comparison of morphologic features and growth control indices. Head Neck Pathol. 2015;9:205–13.PubMedPubMedCentralCrossRefGoogle Scholar
  219. Wolff A, Joshi RK, Ekstrom J, Aframian D, Pedersen AM, Proctor G, Narayana N, Villa A, Sia YW, Aliko A, McGowan R, Kerr AR, Jensen SB, Vissink A, Dawes CA. Guide to medications inducing salivary gland dysfunction, Xerostomia, and subjective Sialorrhea: a systematic review sponsored by the world workshop on oral medicine VI. Drugs R D. 2017;17:1–28.PubMedCrossRefPubMedCentralGoogle Scholar
  220. Woo SB, Schacterle RS, Komaroff AL, Gallagher GT. Salivary gland changes in chronic fatigue syndrome: a case-controlled preliminary histologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:82–7.PubMedCrossRefPubMedCentralGoogle Scholar
  221. Yih WY, Kratochvil FJ, Stewart JC. Intraoral minor salivary gland neoplasms: review of 213 cases. J Oral Maxillofac Surg. 2005;63:805–10.PubMedCrossRefPubMedCentralGoogle Scholar
  222. Zare-Mahmoodabadi R, Salehinejad J, Saghafi S, Ghazi N, Mahmoudi P, Harraji A. Sebaceous adenoma of the submandibular gland: a case report. J Oral Sci. 2009;51:641–4.PubMedCrossRefPubMedCentralGoogle Scholar
  223. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165:2337–44.PubMedCrossRefPubMedCentralGoogle Scholar
  224. Zlotnik Y, Balash Y, Korczyn AD, Giladi N, Gurevich T. Disorders of the oral cavity in Parkinson's disease and parkinsonian syndromes. Parkinsons Dis. 2015;2015:379482.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Siri Beier Jensen
    • 1
    Email author
  • Arjan Vissink
    • 2
  • Norman Firth
    • 3
  1. 1.Department of Dentistry and Oral HealthAarhus UniversityAarhus CDenmark
  2. 2.Department of Oral and Maxillofacial SurgeryUniversity Medical Center Groningen, University of GroningenGroningenThe Netherlands
  3. 3.UWA Dental SchoolUniversity of Western AustraliaNedlandsAustralia

Personalised recommendations